** Medical devices maker Medtronic's shares MDT.N fall 5.7% to $87.49, set to snap a five-day winning streak
** Co posts Q3 sales of $2.07 bln for its surgical devices unit, missing analyst est of $2.13 bln, as per data compiled by LSEG
** Co says a change in buying patterns by its distributors in the U.S. hurt the unit, along with competitive pressures in the surgical staplers market
** MDT reports Q3 adj profit of $1.39/share, higher than analysts' estimates of $1.36/share
** Sales in co's diabetes unit rose 8.4% to $694 million in Q3, beating estimates of $681.8 million
** Co maintains 2025 forecast of $5.44 per share to $5.50 per share
** Stock has risen ~11% in the past 12 months
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com;))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。